4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000009
CEO bought 38,000 shares at an average $0.03 ($985)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-06 | Purchase : show line 1 in the form | +5,000 | $0.03 | $133 | 21,098,623 | D |
| 2019-02-06 | Purchase : show line 2 in the form | +5,000 | $0.03 | $130 | 21,103,623 | D |
| 2019-02-06 | Purchase : show line 3 in the form | +5,000 | $0.03 | $130 | 21,108,623 | D |
| 2019-02-07 | Purchase : show line 4 in the form | +1,000 | $0.03 | $26 | 21,109,623 | D |
| 2019-02-07 | Purchase : show line 5 in the form | +5,000 | $0.03 | $129 | 21,114,623 | D |
| 2019-02-07 | Purchase : show line 6 in the form | +10,000 | $0.03 | $257 | 21,124,623 | D |
| 2019-02-07 | Purchase : show line 7 in the form | +5,000 | $0.03 | $129 | 21,129,623 | D |
| 2019-02-07 | Purchase : show line 8 in the form | +1,000 | $0.03 | $26 | 21,130,623 | D |
| 2019-02-07 | Purchase : show line 9 in the form | +1,000 | $0.03 | $26 | 21,131,623 | D |
| Open-market purchases · 38,000 sh · avg $0.03 · $985 | ||||||
Loading xslF345X03/primary_doc.xml…